Atherosys, Inc.
35Patents
22Active
35Granted
46Portfolio score
Filing activity: Mar 26, 1999 → Aug 25, 2023 · 15 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8147824B2 | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof | Human Necessities | 37 | Active |
| US6361972B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 26 | Expired |
| US6410266B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 25 | Expired |
| US6602686B1 | Compositions and method for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 12 | Expired |
| US6623958B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 12 | Expired |
| US6670185B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 11 | Expired |
| US7981896B2 | Pyrazoles for the treatment of obesity and other CNS disorders | Chemistry; Metallurgy | 9 | Active |
| US6740503B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 8 | Expired |
| US6524818B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 8 | Expired |
| US6897066B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 6 | Expired |
| US9808485B2 | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof | Human Necessities | 6 | Active |
| US6524824B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 4 | Expired |
| US11000546B2 | Immunomodulatory properties of MAPCs and uses thereof | Human Necessities | 4 | Active |
| US6541221B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 4 | Expired |
| US7033782B2 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 3 | Expired |
| US9962407B2 | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof | Human Necessities | 3 | Active |
| US10117900B2 | MAPC treatment of brain injuries and diseases | Human Necessities | 3 | Active |
| US7935830B2 | Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators | Chemistry; Metallurgy | 2 | Active |
| US8129424B2 | Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders | Chemistry; Metallurgy | 1 | Active |
| US7316923B1 | Compositions and methods for non-targeted activation of endogenous genes | Chemistry; Metallurgy | 1 | Expired |
| US11771399B2 | Apparatus and method to guide ultrasound acquisition of the peripheral arteries in the transverse plane | Human Necessities | 1 | Active |
| US7423056B2 | Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US7319103B2 | Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders | Chemistry; Metallurgy | 0 | Expired |
| US8232311B2 | Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US12138114B2 | Apparatus and method to guide ultrasound acquisition of the peripheral arteries in the transverse plane | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.